Price
$1.92
Increased by +5.49%
Dollar volume (20D)
3.20 M
ADR%
7.17
Earnings report date
Nov 12, 2025
Shares float
104.98 M
Shares short
29.15 M [27.77%]
Shares outstanding
105.30 M
Market cap
191.64 M
Beta
2.27
Price/earnings
N/A
20D range
1.50 1.97
50D range
1.50 2.27
200D range
0.77 2.27

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009.

SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Reported date EPSChange YoY EstimateSurprise
Aug 12, 25 -0.07
Increased by +46.15%
-0.08
Increased by +12.50%
May 12, 25 -0.07
Increased by +66.67%
-0.21
Increased by +66.67%
Mar 26, 25 -0.08
Increased by +68.00%
-0.11
Increased by +25.02%
Nov 7, 24 -0.10
Increased by +69.70%
-0.13
Increased by +21.07%
Aug 13, 24 -0.13
Increased by +58.06%
-0.16
Increased by +18.75%
May 14, 24 -0.21
Increased by +55.32%
-0.16
Decreased by -31.25%
Mar 28, 24 -0.25
Increased by +41.86%
0.09
Decreased by -377.78%
Nov 9, 23 -0.33
Increased by +2.94%
0.03
Decreased by -1.20 K%
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 25 0.00
Decreased by N/A%
-6.60 M
Increased by +11.63%
Decreased by N/A%
Decreased by N/A%
Mar 31, 25 0.00
Decreased by N/A%
-5.81 M
Increased by +39.23%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Decreased by N/A%
-6.74 M
Increased by +17.20%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-7.11 M
Increased by +23.30%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-7.47 M
Increased by +15.50%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-9.57 M
Increased by +13.80%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Increased by +100.00%
-8.14 M
Increased by +5.35%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-9.27 M
Decreased by -31.97%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY